Mu H - Search Results

1

In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.

Sassene PJ, Michaelsen MH, Mosgaard MD, Jensen MK, Van Den Broek E, Wasan KM, Mu H, Rades T, Müllertz A. Sassene PJ, et al. Among authors: mu h. Mol Pharm. 2016 Oct 3;13(10):3417-3426. doi: 10.1021/acs.molpharmaceut.6b00413. Epub 2016 Aug 30. Mol Pharm. 2016. PMID: 27533712

2

Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats.

Tønsberg H, Holm R, Mu H, Boll JB, Jacobsen J, Müllertz A. Tønsberg H, et al. Among authors: mu h. J Pharm Pharmacol. 2011 Jun;63(6):817-24. doi: 10.1111/j.2042-7158.2011.01286.x. Epub 2011 May 3. J Pharm Pharmacol. 2011. PMID: 21585380

3

Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology.

Ren S, Mu H, Alchaer F, Chtatou A, Müllertz A. Ren S, et al. Among authors: mu h. Drug Dev Ind Pharm. 2013 May;39(5):799-806. doi: 10.3109/03639045.2012.710634. Epub 2012 Aug 8. Drug Dev Ind Pharm. 2013. PMID: 22871082

4

Lipid-based formulations for oral administration of poorly water-soluble drugs.

Mu H, Holm R, Müllertz A. Mu H, et al. Int J Pharm. 2013 Aug 30;453(1):215-24. doi: 10.1016/j.ijpharm.2013.03.054. Epub 2013 Apr 8. Int J Pharm. 2013. PMID: 23578826 Review.

5

Bile salts and their importance for drug absorption.

Holm R, Müllertz A, Mu H. Holm R, et al. Among authors: mu h. Int J Pharm. 2013 Aug 30;453(1):44-55. doi: 10.1016/j.ijpharm.2013.04.003. Epub 2013 Apr 15. Int J Pharm. 2013. PMID: 23598075 Review.

6

Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.

Christophersen PC, Zhang L, Yang M, Nielsen HM, Müllertz A, Mu H. Christophersen PC, et al. Among authors: mu h. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):473-80. doi: 10.1016/j.ejpb.2013.07.017. Epub 2013 Aug 2. Eur J Pharm Biopharm. 2013. PMID: 23911434

7

Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.

Borkar N, Xia D, Holm R, Gan Y, Müllertz A, Yang M, Mu H. Borkar N, et al. Among authors: mu h. Eur J Pharm Sci. 2014 Jan 23;51:204-10. doi: 10.1016/j.ejps.2013.09.022. Epub 2013 Oct 14. Eur J Pharm Sci. 2014. PMID: 24134899

8

Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release.

Xia D, Cui F, Gan Y, Mu H, Yang M. Xia D, et al. Among authors: mu h. J Pharm Sci. 2014 Feb;103(2):697-705. doi: 10.1002/jps.23830. Epub 2013 Dec 20. J Pharm Sci. 2014. PMID: 24375427

9

Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation.

Christophersen PC, Zhang L, Müllertz A, Nielsen HM, Yang M, Mu H. Christophersen PC, et al. Among authors: mu h. Pharm Res. 2014 Sep;31(9):2420-8. doi: 10.1007/s11095-014-1337-z. Epub 2014 Mar 13. Pharm Res. 2014. PMID: 24623481

10

Solid lipid particles for oral delivery of peptide and protein drugs III - the effect of fed state conditions on the in vitro release and degradation of desmopressin.

Christophersen PC, Vaghela D, Müllertz A, Yang M, Nielsen HM, Mu H. Christophersen PC, et al. Among authors: mu h. AAPS J. 2014 Jul;16(4):875-83. doi: 10.1208/s12248-014-9619-2. Epub 2014 May 30. AAPS J. 2014. PMID: 24875052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,478 results

Search Page

Filters